Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
RegulatoryAbbVie Launches Phase 2 Forehead Lines StudytodayMarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days agoBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramtodayDevices & TechXERF Technology Enters Australian Market for Skin Tightening2 days agoBusiness & M&AEvolus Expands Estyme to Canada, Australia, New ZealandtodayMarketArm Fat Now Top Body Sculpting Concern in Singapore2 days agoDevices & TechSofwave Hits One Million Treatments MilestonetodayRegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days agoRegulatoryRevance Wins FDA Nod for Under-Eye InjectablesyesterdayMarketGLP-1 Pill Era Is Forcing Beauty Market ShiftyesterdayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar DatayesterdayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday
Markets & Filings

8-K

The SEC filing companies must file within days to disclose material events markets need to know now.

Also known as: Current Report, Form 8-K

What it is
An 8-K is a report public companies file with the SEC to disclose material events like acquisitions, executive changes, contract wins, or bankruptcies. It is generally due within four business days of the triggering event. It is the fastest formal channel for material news.
What it does
8-Ks surface tradeable events, contract awards, guidance changes, leadership shakeups, ahead of the next earnings call. Investors monitor EDGAR filings in real time for catalysts. The specific item number signals the type of event.
The evidence
Material 8-Ks disclosing major contract wins or CEO departures routinely move the filer's stock the same day.
Best for
Any single name; especially event-driven and gov-contract stocks.
Pairs well with
form-4, 13f, catalyst
Use cautiously with
Not every 8-K is material to price; boilerplate items get overweighted by inexperienced readers.
Cautions
Language can be intentionally vague, so the market's read may shift as details emerge.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →